Log in to search using one of your social media accounts:


Avedro taps Visiogen founder Zadno for CEO | Personnel Moves Sept. 9 2016

Avedro taps Visiogen founder Zadno for CEO Avedro said it named the founder, president of Abbott (NYSE:ABT) acquisition Visiogen, Reza Zadno, to be its new CEO. Zadno replaces CFO/COO Brian Roberts, the former CFO at Insulet (NSDQ:PODD), who stepped in on an interim basis when David Muller bowed out shortly after Avedro closed a $32 million equity round in November 2015. In September 2009, Abbott paid $400 million for Visiogen and its Synchrony accommodating intraocular lens for treating presbyopia in cataract patients. Zadno was also chairman at a pair of other eye care companies that were bought by larger companies: Transcend Medical, acquired by Novartis (NYSE:NVS) unit Alcon in February, and Oraya Therapeutics, which was picked up by Carl Zeiss Meditec (ETR:AFX). “We are very pleased to have Reza join Avedro’s senior executive team as CEO,” director Dr. Gil Kliman, managing director at InterWest Partners, said in prepared remarks. “His entrepreneurial skills and proven leadership will help assure the successful commercialization of our recently FDA approved cross-linking device and drugs in the United States, and speed our clinical development of PiXL, a first-in-category, non-surgical procedure for the correction of myopia.” “It’s been exciting to watch Avedro make tremendous strides in bringing corneal cross-linking to market,” Zadno added. “I’m honored to join this team of talented professionals an...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Avedro Inc. DJO Global EnteroMedics Inc. Personnel Moves Source Type: news

Related Links:

More News: Cataracts | Medical Devices | Mergers and Aquisitions | Myopia (short sighted) | Study